| Application number | Title of the application | Filing Date | Status |
|---|
Array
(
[id] => 4329063
[patent_doc_number] => 06319928
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-11-20
[patent_title] => 'Purine derivatives having phosphodiesterase IV inhibition activity'
[patent_app_type] => 1
[patent_app_number] => 9/418331
[patent_app_country] => US
[patent_app_date] => 1999-10-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20281
[patent_no_of_claims] => 50
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 147
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/319/06319928.pdf
[firstpage_image] =>[orig_patent_app_number] => 418331
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/418331 | Purine derivatives having phosphodiesterase IV inhibition activity | Oct 13, 1999 | Issued |
Array
(
[id] => 4409889
[patent_doc_number] => 06300334
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-10-09
[patent_title] => 'Thieno[2,3-d]pyrimidine-2,4-diones'
[patent_app_type] => 1
[patent_app_number] => 9/402837
[patent_app_country] => US
[patent_app_date] => 1999-10-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23178
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 783
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/300/06300334.pdf
[firstpage_image] =>[orig_patent_app_number] => 402837
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/402837 | Thieno[2,3-d]pyrimidine-2,4-diones | Oct 12, 1999 | Issued |
Array
(
[id] => 4420493
[patent_doc_number] => 06194576
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-02-27
[patent_title] => 'Process for preparing antiviral 2-phosponate nucleotide analogs'
[patent_app_type] => 1
[patent_app_number] => 9/411980
[patent_app_country] => US
[patent_app_date] => 1999-10-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 41846
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 412
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/194/06194576.pdf
[firstpage_image] =>[orig_patent_app_number] => 411980
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/411980 | Process for preparing antiviral 2-phosponate nucleotide analogs | Oct 3, 1999 | Issued |
Array
(
[id] => 4307008
[patent_doc_number] => 06252067
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-06-26
[patent_title] => 'Method of preparing oxoquazepam'
[patent_app_type] => 1
[patent_app_number] => 9/410031
[patent_app_country] => US
[patent_app_date] => 1999-10-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1069
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 59
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/252/06252067.pdf
[firstpage_image] =>[orig_patent_app_number] => 410031
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/410031 | Method of preparing oxoquazepam | Sep 30, 1999 | Issued |
Array
(
[id] => 4411820
[patent_doc_number] => 06300495
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-10-09
[patent_title] => 'Process for the preparation of a metal salt of clavulanic acid'
[patent_app_type] => 1
[patent_app_number] => 9/402231
[patent_app_country] => US
[patent_app_date] => 1999-09-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 4517
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 53
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/300/06300495.pdf
[firstpage_image] =>[orig_patent_app_number] => 402231
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/402231 | Process for the preparation of a metal salt of clavulanic acid | Sep 29, 1999 | Issued |
Array
(
[id] => 4383502
[patent_doc_number] => 06277857
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-08-21
[patent_title] => 'Fungicidal 7-oxy-and 7-thio-substituted-triazolopyrimidines'
[patent_app_type] => 1
[patent_app_number] => 9/405412
[patent_app_country] => US
[patent_app_date] => 1999-09-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6235
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/277/06277857.pdf
[firstpage_image] =>[orig_patent_app_number] => 405412
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/405412 | Fungicidal 7-oxy-and 7-thio-substituted-triazolopyrimidines | Sep 23, 1999 | Issued |
Array
(
[id] => 4185593
[patent_doc_number] => 06159974
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-12-12
[patent_title] => 'LDL receptor gene expression promoters'
[patent_app_type] => 1
[patent_app_number] => 9/381829
[patent_app_country] => US
[patent_app_date] => 1999-09-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11284
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/159/06159974.pdf
[firstpage_image] =>[orig_patent_app_number] => 381829
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/381829 | LDL receptor gene expression promoters | Sep 23, 1999 | Issued |
Array
(
[id] => 4304685
[patent_doc_number] => 06187781
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-02-13
[patent_title] => '4-Tetrahydropyridylpyrimidine derivatives'
[patent_app_type] => 1
[patent_app_number] => 9/381462
[patent_app_country] => US
[patent_app_date] => 1999-09-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9522
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 220
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/187/06187781.pdf
[firstpage_image] =>[orig_patent_app_number] => 381462
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/381462 | 4-Tetrahydropyridylpyrimidine derivatives | Sep 20, 1999 | Issued |
Array
(
[id] => 4383286
[patent_doc_number] => 06277844
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-08-21
[patent_title] => 'Compound for selective treatment of malignant cells by inhibiting cell cycle progression, decreasing Bcl2, and increasing apoptosis'
[patent_app_type] => 1
[patent_app_number] => 9/395812
[patent_app_country] => US
[patent_app_date] => 1999-09-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 15
[patent_no_of_words] => 9516
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 81
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/277/06277844.pdf
[firstpage_image] =>[orig_patent_app_number] => 395812
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/395812 | Compound for selective treatment of malignant cells by inhibiting cell cycle progression, decreasing Bcl2, and increasing apoptosis | Sep 13, 1999 | Issued |
| 09/380380 | COMPOUNDS | Aug 31, 1999 | Abandoned |
Array
(
[id] => 4420414
[patent_doc_number] => 06194569
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-02-27
[patent_title] => 'Efficient process for the preparation of [S-(R,S)]-N-[1,3-benzodioxol-5-yl)butyl]-3,3-diethyl-2[4-[4-methyl-1-piper azinyl)carbonyl]phenoxy]-4-oxo-1-azetidine carboxamide, a human leukocyte elastase inhibitor'
[patent_app_type] => 1
[patent_app_number] => 9/385271
[patent_app_country] => US
[patent_app_date] => 1999-08-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11066
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 61
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/194/06194569.pdf
[firstpage_image] =>[orig_patent_app_number] => 385271
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/385271 | Efficient process for the preparation of [S-(R,S)]-N-[1,3-benzodioxol-5-yl)butyl]-3,3-diethyl-2[4-[4-methyl-1-piper azinyl)carbonyl]phenoxy]-4-oxo-1-azetidine carboxamide, a human leukocyte elastase inhibitor | Aug 29, 1999 | Issued |
Array
(
[id] => 4371091
[patent_doc_number] => 06288075
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-09-11
[patent_title] => 'Thiazolo[5,4,3-ij]quinolines, preparation and medicines containing the same'
[patent_app_type] => 1
[patent_app_number] => 9/384237
[patent_app_country] => US
[patent_app_date] => 1999-08-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 36945
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 198
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/288/06288075.pdf
[firstpage_image] =>[orig_patent_app_number] => 384237
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/384237 | Thiazolo[5,4,3-ij]quinolines, preparation and medicines containing the same | Aug 26, 1999 | Issued |
Array
(
[id] => 4316941
[patent_doc_number] => 06242599
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-06-05
[patent_title] => 'Process for the preparation of guanine'
[patent_app_type] => 1
[patent_app_number] => 9/384215
[patent_app_country] => US
[patent_app_date] => 1999-08-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1724
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 44
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/242/06242599.pdf
[firstpage_image] =>[orig_patent_app_number] => 384215
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/384215 | Process for the preparation of guanine | Aug 26, 1999 | Issued |
Array
(
[id] => 1470743
[patent_doc_number] => 06407236
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-06-18
[patent_title] => 'Adenosine A3 receptor modulators'
[patent_app_type] => B1
[patent_app_number] => 09/379300
[patent_app_country] => US
[patent_app_date] => 1999-08-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 18962
[patent_no_of_claims] => 43
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 211
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/407/06407236.pdf
[firstpage_image] =>[orig_patent_app_number] => 09379300
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/379300 | Adenosine A3 receptor modulators | Aug 22, 1999 | Issued |
Array
(
[id] => 1514810
[patent_doc_number] => 06420375
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-07-16
[patent_title] => 'Fused ring compounds, process for producing the same and use thereof'
[patent_app_type] => B1
[patent_app_number] => 09/367896
[patent_app_country] => US
[patent_app_date] => 1999-08-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 28221
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/420/06420375.pdf
[firstpage_image] =>[orig_patent_app_number] => 09367896
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/367896 | Fused ring compounds, process for producing the same and use thereof | Aug 17, 1999 | Issued |
Array
(
[id] => 4251234
[patent_doc_number] => 06137007
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-10-24
[patent_title] => 'Enantiomer compositions of (1R,4S)-1-butyrylamino-4-(hydroxymethyl)-2-cyclopentene'
[patent_app_type] => 1
[patent_app_number] => 9/373862
[patent_app_country] => US
[patent_app_date] => 1999-08-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 11003
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/137/06137007.pdf
[firstpage_image] =>[orig_patent_app_number] => 373862
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/373862 | Enantiomer compositions of (1R,4S)-1-butyrylamino-4-(hydroxymethyl)-2-cyclopentene | Aug 12, 1999 | Issued |
Array
(
[id] => 4326881
[patent_doc_number] => 06329382
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-12-11
[patent_title] => 'Pyrrolo[3,2-e]pyrazolo[1,5-a]pyrimidine remedies/preventives for respiratory diseases'
[patent_app_type] => 1
[patent_app_number] => 9/355935
[patent_app_country] => US
[patent_app_date] => 1999-08-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9936
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 141
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/329/06329382.pdf
[firstpage_image] =>[orig_patent_app_number] => 355935
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/355935 | Pyrrolo[3,2-e]pyrazolo[1,5-a]pyrimidine remedies/preventives for respiratory diseases | Aug 12, 1999 | Issued |
Array
(
[id] => 1507891
[patent_doc_number] => 06440972
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-08-27
[patent_title] => 'Heterocyclic compounds useful as oxido-squalene cyclase inhibitors'
[patent_app_type] => B1
[patent_app_number] => 09/367400
[patent_app_country] => US
[patent_app_date] => 1999-08-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11243
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/440/06440972.pdf
[firstpage_image] =>[orig_patent_app_number] => 09367400
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/367400 | Heterocyclic compounds useful as oxido-squalene cyclase inhibitors | Aug 12, 1999 | Issued |
Array
(
[id] => 4352895
[patent_doc_number] => 06215004
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-04-10
[patent_title] => 'Method of manufacture of 1,3-oxathiolane nucleosides'
[patent_app_type] => 1
[patent_app_number] => 9/373891
[patent_app_country] => US
[patent_app_date] => 1999-08-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 12245
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 76
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/215/06215004.pdf
[firstpage_image] =>[orig_patent_app_number] => 373891
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/373891 | Method of manufacture of 1,3-oxathiolane nucleosides | Aug 11, 1999 | Issued |
| 09/367107 | PROCESS FOR THE CRYSTALLIZATION FROM A LINEAR OR BRANCHED (C5-C6) ALCOHOL OR THEIR MIXTURES OF (S)-N,N'-BIS[2-HYDROXY-1-(HYDROXYMETHYL) ETHYL]-5-[(2-HYDROXY-1-OXOPROPY)AMINO]-2,4,6-TRIIODO-1,3- BENZENDICARBOXAMIDE | Aug 9, 1999 | Abandoned |